Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M McLaughlin

Showing results (41-50 of 97) with videos related to

Pageof 10
Sort By:
The Lancet. Respiratory Medicine|April 25, 2022
Durability of BNT162b2 vaccine against hospital and emergency department admissions due to the omicron and delta variants in a large health system in the USA: a test-negative case-control studySara Y Tartof, Jeff M Slezak, Laura Puzniak, et al.
The American Journal of Managed Care|August 30, 2021
Hospital discharge diagnosis position: impact on adult pneumonia burden estimatesJose A Suaya, Ermias Tilahun, Vannessa Harrison, et al.
The Lancet. Respiratory Medicine|May 9, 2022
Immunocompromise and durability of BNT162b2 vaccine against severe outcomes due to omicron and delta variantsSara Y Tartof, Jeff M Slezak, Laura Puzniak, et al.
Scientific Reports|September 11, 2021
Continued need for non-pharmaceutical interventions after COVID-19 vaccination in long-term-care facilitiesJay Love, Lindsay T Keegan, Frederick J Angulo, et al.
Current Medical Research and Opinion|May 6, 2025
A letter to the editor in response to: indirect comparison of the relative vaccine effectiveness of mRNA-1283 vs. BNT162b2 vaccines against symptomatic COVID-19 among US adultsHannah R Volkman, Santiago M C Lopez, Mary M Moran, et al.
Expert Review of Vaccines|December 17, 2022
Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical dataJingyan Yang, Shailja Vaghela, Benjamin Yarnoff, et al.
Plos One|January 6, 2022
Pandemic-related declines in hospitalization for non-COVID-19-related illness in the United States from January through July 2020Jennifer L Nguyen, Michael Benigno, Deepa Malhotra, et al.
JAMA Network Open|November 8, 2023
Estimated Effectiveness of Coadministration of the BNT162b2 BA.4/5 COVID-19 Vaccine With Influenza VaccineLeah J McGrath, Deepa Malhotra, Amanda C Miles, et al.
Infectious Diseases and Therapy|January 13, 2024
Nirmatrelvir/Ritonavir Utilization for the Treatment of Non-hospitalized Adults with COVID-19 in the National Veterans Affairs (VA) Healthcare SystemHaley J Appaneal, Kerry L LaPlante, Vrishali V Lopes, et al.
Infectious Diseases and Therapy|June 23, 2024
Perceived Risk for Severe COVID-19 and Oral Antiviral Use Among Antiviral-Eligible US AdultsKate Penrose, Avantika Srivastava, Yanhan Shen, et al.
Pageof 10

Showing results (41-50 of 97) with videos related to

Sort By:
Pageof 10
The Lancet. Respiratory Medicine|April 25, 2022
Durability of BNT162b2 vaccine against hospital and emergency department admissions due to the omicron and delta variants in a large health system in the USA: a test-negative case-control studySara Y Tartof, Jeff M Slezak, Laura Puzniak, et al.
The American Journal of Managed Care|August 30, 2021
Hospital discharge diagnosis position: impact on adult pneumonia burden estimatesJose A Suaya, Ermias Tilahun, Vannessa Harrison, et al.
The Lancet. Respiratory Medicine|May 9, 2022
Immunocompromise and durability of BNT162b2 vaccine against severe outcomes due to omicron and delta variantsSara Y Tartof, Jeff M Slezak, Laura Puzniak, et al.
Scientific Reports|September 11, 2021
Continued need for non-pharmaceutical interventions after COVID-19 vaccination in long-term-care facilitiesJay Love, Lindsay T Keegan, Frederick J Angulo, et al.
Current Medical Research and Opinion|May 6, 2025
A letter to the editor in response to: indirect comparison of the relative vaccine effectiveness of mRNA-1283 vs. BNT162b2 vaccines against symptomatic COVID-19 among US adultsHannah R Volkman, Santiago M C Lopez, Mary M Moran, et al.
Expert Review of Vaccines|December 17, 2022
Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical dataJingyan Yang, Shailja Vaghela, Benjamin Yarnoff, et al.
Plos One|January 6, 2022
Pandemic-related declines in hospitalization for non-COVID-19-related illness in the United States from January through July 2020Jennifer L Nguyen, Michael Benigno, Deepa Malhotra, et al.
JAMA Network Open|November 8, 2023
Estimated Effectiveness of Coadministration of the BNT162b2 BA.4/5 COVID-19 Vaccine With Influenza VaccineLeah J McGrath, Deepa Malhotra, Amanda C Miles, et al.
Infectious Diseases and Therapy|January 13, 2024
Nirmatrelvir/Ritonavir Utilization for the Treatment of Non-hospitalized Adults with COVID-19 in the National Veterans Affairs (VA) Healthcare SystemHaley J Appaneal, Kerry L LaPlante, Vrishali V Lopes, et al.
Infectious Diseases and Therapy|June 23, 2024
Perceived Risk for Severe COVID-19 and Oral Antiviral Use Among Antiviral-Eligible US AdultsKate Penrose, Avantika Srivastava, Yanhan Shen, et al.
Pageof 10